HOME >> BIOLOGY >> NEWS
Major breakthrough in understanding how HIV interferes with infected cell division

Montral, July 12, 2007 Dr. ric A. Cohen, a researcher at the IRCM (Institut de recherches cliniques de Montral), and his team will publish on Friday, July 13, in PLoS Pathogens a discovery that could lead to the development of a new class of drugs to combat HIV.

Human immunodeficiency virus type 1 (HIV-1) causes AIDS by depleting essential immune cells called CD4+T lymphocytes in infected individuals, resulting in a compromised immune system. At the center of this process is the HIV protein, viral protein R (Vpr), which stops infected CD4+T cells from dividing and as a consequence compromises their immune function. In addition, by arresting cell division, Vpr helps HIV to harness the infected cells resources to enhance viral replication. The way Vpr exerts this effect is by interacting with cellular proteins that control cell division.

Dr. Cohen and his team have identified a novel cellular protein complex targeted by HIV-1 Vpr to stop infected cell division. This protein complex, designated DDB1-CUL4-VprBP, is involved in a process called ubiquitination. Ubiquitination is a mechanism by which a small protein called ubiquitin is conjugated to cellular proteins in order to modulate their biological activity or induce their degradation. The researchers demonstrated that association of Vpr with this ubiquitinating complex, also called an E3 ubiquitin ligase complex, is essential for the defect in cell division induced by Vpr. Further characterization of this protein complex as well as the elucidation of the mechanism by which it affects cell division may open new avenues for therapeutic intervention against HIV.


'"/>

Contact: Lucette Thriault
lucette.theriault@ircm.qc.ca
514-987-5535
Institut de recherches cliniques de Montreal
12-Jul-2007


Page: 1

Related biology news :

1. Major study predicts grim future for Europes seas
2. Major genetic study identifies clearest link yet to obesity risk
3. Major gene study uncovers secrets of leukemia
4. Major society publisher announces support for public access to scientific literature
5. Major link in brain-obesity puzzle found
6. Major Wellcome Trust award to take science from the bench to the bedside
7. Major breakthrough in the mechanism of myelin formation
8. Major new osteoporosis study to recruit people in Orkney
9. Major genetic risk factor found for prostate cancer
10. Major report on tigers to be released Thursday at National Zoo
11. Major initiative proposed to address amphibian crisis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/30/2019)... Md. (PRWEB) , ... September ... ... biotechnology market disrupter and leading supplier of innovative human mesenchymal stem/stromal cell ... for novel product formulations related to “Ready-to-Print” (RTP) cellular product formats (patent ...
(Date:9/25/2019)... ... September 25, 2019 , ... LeadingBiotech , an ... today announces its inaugural South CEO conference to be held on ... Co-produced by Tulane University, this invitation-only meeting convenes biopharma executives to discuss pressing ...
(Date:9/24/2019)... (PRWEB) , ... September 24, 2019 , ... ... companies characterize protein interactions for accelerated drug development, announced today that it has ... was led by OS Fund and also includes AME Cloud Ventures, Boom Capital, ...
Breaking Biology News(10 mins):
(Date:10/22/2019)... ... October 22, 2019 , ... Catalent, a global leader in ... Drug Product Technologies Integration, will participate in a panel session titled “Cell and Gene ... held at the Gwen Hotel, Chicago, on Oct. 28-30, 2019. , The panel session, ...
(Date:10/15/2019)... ... October 14, 2019 , ... ARPR , an award-winning tech PR agency at ... as a Health Care Agency of the Year in the Ragan’s Health Care PR ... a finalist by Ragan’s. The firm also revealed today that its healthIT practice group grew ...
(Date:10/8/2019)... ... October 08, 2019 , ... As Keck ... Leslie Maurer presented company executives with a set of recommendations to enhance supply ... offer insights from their TMP to a wider audience of industry leaders attending ...
(Date:10/3/2019)... ... October 02, 2019 , ... Today marked ... that is enabling clinical program outsourcing success by cultivating radical improvements in leadership, ... biotech veteran executive Brenda Reese, phaseUP™ brings clients deep, broad and unique expertise ...
Breaking Biology Technology:
Cached News: